Transplante – Coração

Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.

7 Dez, 2021 | 11:29h

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial – Clinical Infectious Diseases

---

FDA autoriza aplicação de dose adicional da vacina contra Covid-19 em indivíduos imunocomprometidos – As demais pessoas, já plenamente vacinadas, não precisam de dose adicional neste momento.

16 Ago, 2021 | 12:10h

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals – U.S. Food & Drug Administration

Comentários:

Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients – Infectious Diseases Society of America

CDC, FDA recommend COVID booster for immune-compromised – CIDRAP

FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT

The fine print: Understanding the new policy authorizing extra Covid vaccine doses for the immunocompromised – STAT

Covid booster: US approves third jab for the immunocompromised – BBC

CDC Committee Approves Third Covid-19 Shot For Immunocompromised People—Here’s Who Should Get One – Forbes

CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR

6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR

CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN

 

Comentário no Twitter

The Infectious Diseases Society of America (IDSA) supports the @FDA and @CDCgov's decision to authorize a supplemental vaccine dose for immunocompromised patients.

Read our statement: https://t.co/odzzSgIxnY pic.twitter.com/4PZfUwpjhM

— IDSA (@IDSAInfo) August 13, 2021

 

---

Estudo randomizado | Terceira dose da vacina de mRNA da Moderna aumenta a imunidade em receptores de transplantes.

12 Ago, 2021 | 12:28h

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients – New England Journal of Medicine

Editorial: Third Time’s a Charm — Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients

Conteúdos relacionados:

Study: Among kidney transplant recipients who did not respond after 2 doses, a third dose of an mRNA-1273 vaccine induced a serologic response in 49% of patients.

Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.

[Preprint] 3rd AstraZeneca shot gives strong immunity.

 

Comentários no Twitter

..1st randomized trial results of 3rd doses of Moderna vax for 120 people with organ transplants: month 4, their minimum anti-RBD antibody levels were 55% for 3rd dose vs 18% (still increasing a little in the placebo group). No cases of acute rejection https://t.co/BcfeyUEhx5 #IC

— Hilda Bastian, PhD (@hildabast) August 11, 2021

The authors conclude that a third-dose booster of mRNA-1273 vaccine should be considered for transplant recipients. https://t.co/Q3gakSaNjd pic.twitter.com/CMN8f7cq29

— NEJM (@NEJM) August 11, 2021

 

---

Uso de drogas por doadores não está associado com piora na sobrevida do receptor de transplante cardíaco – “Aumento do uso de tais doadores pode ajudar a aliviar a escassez crônica de doadores.”

2 Ago, 2021 | 17:58h

Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety – Circulation: Heart Failure

Comentário: Donor Drug Use Not Tied to Survival for Heart Transplant Recipients – HealthDay

Estudo relacionado: National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? – Circulation: Heart Failure

---

3 doses de vacina de mRNA contra Covid-19 em receptores de transplante de órgão sólido pode melhorar a imunogenicidade da vacina.

24 Jun, 2021 | 11:05h

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients – New England Journal of Medicine

---

Série de casos | Segurança e imunogenicidade de uma terceira dose de vacina contra SARS-CoV-2 em transplantados receptores de órgãos sólidos.

15 Jun, 2021 | 11:24h

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series – Annals of Internal Medicine

Comentários: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection – Hopkins Medicine E Extra COVID Vaccine May Help Protect Transplant Patients – Associated Press

 

Comentário no Twitter

Our report about 3rd vaccine doses in transplant patients is published! "It is encouraging that antibody titers increased after the 3rd dose in 1/3 of patients who had negative antibody titers and in all patients who had low-positive antibody titers"https://t.co/6XElwyIdAa

— Dorry Segev (@Dorry_Segev) June 14, 2021

 

---